High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Technicals: Bullish SharesGuru indicator.
Momentum: Stock is suffering a negative price momentum. Stock is down -8.9% in last 30 days.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.4% return compared to 13.3% by NIFTY 50.
Valuation | |
|---|---|
| Market Cap | 1.24 kCr |
| Price/Earnings (Trailing) | 20.67 |
| Price/Sales (Trailing) | 1.38 |
| EV/EBITDA | 14.46 |
| Price/Free Cashflow | -94.79 |
| MarketCap/EBT | 16.6 |
| Enterprise Value | 1.26 kCr |
Fundamentals | |
|---|---|
| Revenue (TTM) | 902.73 Cr |
| Rev. Growth (Yr) | 1.9% |
| Earnings (TTM) | 60.07 Cr |
| Earnings Growth (Yr) | -37.1% |
Profitability | |
|---|---|
| Operating Margin | 10% |
| EBT Margin | 8% |
| Return on Equity | 5.54% |
| Return on Assets | 4.64% |
| Free Cashflow Yield | -1.05% |
Growth & Returns | |
|---|---|
| Price Change 1W | -3.3% |
| Price Change 1M | -8.9% |
| Price Change 6M | -23.7% |
| Price Change 1Y | -27.2% |
| 3Y Cumulative Return | -1.4% |
| 5Y Cumulative Return | 9.6% |
| 7Y Cumulative Return | 3.2% |
| 10Y Cumulative Return | -0.50% |
Cash Flow & Liquidity | |
|---|---|
| Cash Flow from Investing (TTM) | 20.1 Cr |
| Cash Flow from Operations (TTM) | -3.98 Cr |
| Cash Flow from Financing (TTM) | -18.08 Cr |
| Cash & Equivalents | 12.7 Cr |
| Free Cash Flow (TTM) | -16.82 Cr |
| Free Cash Flow/Share (TTM) | -11.9 |
Balance Sheet | |
|---|---|
| Total Assets | 1.3 kCr |
| Total Liabilities | 210.47 Cr |
| Shareholder Equity | 1.09 kCr |
| Current Assets | 1.17 kCr |
| Current Liabilities | 205.27 Cr |
| Net PPE | 78.44 Cr |
| Inventory | 102.13 Cr |
| Goodwill | 0.00 |
Capital Structure & Leverage | |
|---|---|
| Debt Ratio | 0.02 |
| Debt/Equity | 0.02 |
| Interest Coverage | 22.4 |
| Interest/Cashflow Ops | -0.23 |
Dividend & Shareholder Returns | |
|---|---|
| Dividend/Share (TTM) | 10 |
| Dividend Yield | 1.04% |
| Shares Dilution (1Y) | 0.00% |
| Shares Dilution (3Y) | 0.00% |
High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 4 years
Balance Sheet: Strong Balance Sheet.
Buy Backs: Company has bought back it's stock in the past which is a good thing.
Smart Money: Smart money is taking extra interest in the stock as they increase their holdings.
Technicals: Bullish SharesGuru indicator.
Momentum: Stock is suffering a negative price momentum. Stock is down -8.9% in last 30 days.
Past Returns: Underperforming stock! In past three years, the stock has provided -1.4% return compared to 13.3% by NIFTY 50.
Investor Care | |
|---|---|
| Dividend Yield | 1.04% |
| Dividend/Share (TTM) | 10 |
| Shares Dilution (1Y) | 0.00% |
| Earnings/Share (TTM) | 42.51 |
Financial Health | |
|---|---|
| Current Ratio | 5.68 |
| Debt/Equity | 0.02 |
Technical Indicators | |
|---|---|
| RSI (14d) | 7.03 |
| RSI (5d) | 2.08 |
| RSI (21d) | 13.92 |
| MACD Signal | Sell |
| Stochastic Oscillator Signal | Buy |
| SharesGuru Signal | Buy |
| RSI Signal | Buy |
| RSI5 Signal | Buy |
| RSI21 Signal | Buy |
| SMA 5 Signal | Sell |
| SMA 10 Signal | Sell |
| SMA 20 Signal | Sell |
| SMA 50 Signal | Sell |
| SMA 100 Signal | Sell |
Summary of TTK Healthcare's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.
Analysis of TTK Healthcare's financial performance, highlighting revenue trends, growth patterns, and key metrics through quarterly analysis.
No revenue data available.
Understand TTK Healthcare ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.
| Shareholder Name | Holding % |
|---|---|
| T T KRISHNAMACHARI & CO. represented by its Partners - Mr T T Jagannathan and Mr T T Raghunathan | 67.46% |
| SARAYU THIRUVALLUR THATTAI (Duly represented by Ms. Maitri Gopalakrishna, her Mother and Natural Guardian) | 1.89% |
| MUKUND THIRUVALLUR THATTAI | 1.89% |
| TIRUVALLUR THATAI LAKSHMAN | 1.89% |
| Foreign Institutional Investors | 1.89% |
| JUPITER INDIA FUND | 1.52% |
| Investor Education and Protection Fund (IEPF) | 1.07% |
| SHANTHI RANGANATHAN | 0.41% |
| BHANU RAGHUNATHAN | 0.4% |
| T T RAGHUNATHAN | 0.27% |
| LATHA JAGANNATHAN | 0.21% |
| TTK TANTEX LIMITED | 0.06% |
| PACKWELL PACKAGING PRODUCTS LIMITED | 0.06% |
| TTK PRESTIGE LIMITED | 0.01% |
| STINA OSTLUND VASU | 0% |
Distribution across major stakeholders
Distribution across major institutional holders
Detailed comparison of TTK Healthcare against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.
Ticker | Name | Mkt Cap | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
|---|---|---|---|---|---|---|---|---|---|
| ABBOTINDIA | Abbott India | 59.24 kCr | 7.11 kCr | +0.80% | -11.80% | 38.1 | 8.46 | - | - |
| GLAXO | GlaxoSmithkline Pharmaceuticals | 42.64 kCr | 3.95 kCr | +4.60% | -6.40% | 42.5 | 10.79 | - | - |
| POLYMED | Poly Medicure | 13.75 kCr | 1.91 kCr | -10.60% | -41.60% | 39.69 | 7.2 | - | - |
| SANOFI | Sanofi India | 8.71 kCr | 1.86 kCr | -6.20% | -29.90% | 26.67 | 4.69 | - | - |
| OPTOCIRCUI | Opto Circuits (India) | 53.51 Cr | - | 0.00% | 0.00% | - | - | - | - |
Comprehensive comparison against sector averages
TTKHLTCARE metrics compared to Diversified
| Category | TTKHLTCARE | Diversified |
|---|---|---|
| PE | 20.25 | 31.80 |
| PS | 1.35 | 1.98 |
| Growth | 4.9 % | 3.5 % |
TTK Healthcare Limited engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India. It operates through Animal Welfare, Consumer Products, Medical Devices, Protective Devices, Foods, Human Pharma, and Others segments. The Animal Welfare segment offers various feed supplements, liver correctives, fertility inducers, antibiotics, anti-parasiticides, antispasmodics, cervical dilators, cocktail enzymes, etc. to veterinarians, dairy, poultry and aqua farmers, and pet parents. The Consumer Products segment is involved in the marketing and distribution of baby care products under the Woodward's Gripewater name; personal care products and cosmetics under the EVA name; home care products, such as scrubbers under the Good Home name; and air fresheners. The Medical Devices segment manufactures and markets artificial heart valves under the TTK Chitra name, as well as orthopedic implants and instruments for knee and hip replacements. The Protective Devices segment manufactures and markets sexual wellness products, including male contraceptives under the Skore brand name, and other allied products. The Foods segment engages in the manufacturing and marketing of food products, including papads under the Fryums name; and cereal, potato, rice, pulses, and corn-based products. The Human Pharma is involved in the development and commercialization of such as gynecology, infertility, respiratory, orthopedics, cardiology, and general health therapeutic needs. The Others segment prints and publishes maps, atlases, guidebooks, and educational publications under the TTK brand name. The company was founded in 1928 and is headquartered in Chennai, India. TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
This is an informational page just to provide a quick 'first look' at the stock. You must do your own deeper research. Know your risk appetite. Consult a SEBI-registered financial advisor before making any investment decisions.
TTKHLTCARE vs Diversified (2021 - 2026)